BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30782136)

  • 1. Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report.
    Adachi Y; Hayashi T; Mitsuhashi T; Sakakura K; Yamada Y; Wada Y; Horie M; Momomura SI; Fujita H
    BMC Cardiovasc Disord; 2019 Feb; 19(1):41. PubMed ID: 30782136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutation of plakophilin-2 associated with arrhythmogenic right ventricular cardiomyopathy.
    Nagaoka I; Matsui K; Ueyama T; Kanemoto M; Wu J; Shimizu A; Matsuzaki M; Horie M
    Circ J; 2006 Jul; 70(7):933-5. PubMed ID: 16799251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
    Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
    Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.
    Bhonsale A; Te Riele ASJM; Sawant AC; Groeneweg JA; James CA; Murray B; Tichnell C; Mast TP; van der Pols MJ; Cramer MJM; Dooijes D; van der Heijden JF; Tandri H; van Tintelen JP; Judge DP; Hauer RNW; Calkins H
    Heart Rhythm; 2017 Jun; 14(6):883-891. PubMed ID: 28215569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy.
    Biernacka EK; Borowiec K; Franaszczyk M; Szperl M; Rampazzo A; Woźniak O; Roszczynko M; Śmigielski W; Lutyńska A; Hoffman P
    J Appl Genet; 2021 Dec; 62(4):613-620. PubMed ID: 34191271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    van Tintelen JP; Entius MM; Bhuiyan ZA; Jongbloed R; Wiesfeld AC; Wilde AA; van der Smagt J; Boven LG; Mannens MM; van Langen IM; Hofstra RM; Otterspoor LC; Doevendans PA; Rodriguez LM; van Gelder IC; Hauer RN
    Circulation; 2006 Apr; 113(13):1650-8. PubMed ID: 16567567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of PKP2 and neighbouring genes in a patient with arrhythmogenic right ventricular cardiomyopathy caused by heterozygous PKP2 deletion.
    Sonoda K; Ohno S; Otuki S; Kato K; Yagihara N; Watanabe H; Makiyama T; Minamino T; Horie M
    Europace; 2017 Apr; 19(4):644-650. PubMed ID: 28431057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy.
    Bao J; Wang J; Yao Y; Wang Y; Fan X; Sun K; He DS; Marcus FI; Zhang S; Hui R; Song L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):552-6. PubMed ID: 24125834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
    Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy.
    Perrin MJ; Angaran P; Laksman Z; Zhang H; Porepa LF; Rutberg J; James C; Krahn AD; Judge DP; Calkins H; Gollob MH
    J Am Coll Cardiol; 2013 Nov; 62(19):1772-9. PubMed ID: 23810883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical analysis of plakophilin-2 gene mutation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia].
    Liu X; Liu W; Hu D; Zhang L; Zhu T; Li C; Qiu X; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Qin X; Lan Y
    Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1001-6. PubMed ID: 26887364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
    Smith W;
    Heart Lung Circ; 2011 Dec; 20(12):757-60. PubMed ID: 21885338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Variant Score and Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Plakophilin-2 Mutation Carriers.
    Svensson A; Platonov PG; Haugaa KH; Zareba W; Jensen HK; Bundgaard H; Gilljam T; Madsen T; Hansen J; Dejgaard LA; Karlsson LO; Gréen A; Polonsky B; Edvardsen T; Svendsen JH; Gunnarsson C
    Cardiology; 2021; 146(6):763-771. PubMed ID: 34469894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel frame-shift mutation in PKP2 associated with arrhythmogenic right ventricular cardiomyopathy: a case report.
    Trenkwalder T; Deisenhofer I; Hadamitzky M; Schunkert H; Reinhard W
    BMC Med Genet; 2015 Dec; 16():117. PubMed ID: 26701096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.
    Costa S; Medeiros-Domingo A; Gasperetti A; Akdis D; Berger W; James CA; Ruschitzka F; Brunckhorst CB; Duru F; Saguner AM
    Circ Genom Precis Med; 2021 Feb; 14(1):e003047. PubMed ID: 33232181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile in arrhythmogenic cardiomyopathy and a recessive plakophilin-2 gene mutation.
    Ali M; Bhat IA; Hafeez I; Dar MI; Beig JR; Shah ZA; Iqbal K
    Indian Heart J; 2018; 70(3):421-426. PubMed ID: 29961461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel plakophilin2 mutation: three-generation family with arrhythmogenic right ventricular cardiomyopathy.
    Aneq MÅ; Fluur C; Rehnberg M; Söderkvist P; Engvall J; Nylander E; Gunnarsson C
    Scand Cardiovasc J; 2012 Apr; 46(2):72-5. PubMed ID: 22035158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.